Stichting Epilepsy Instellingen Nederland
- Address
- lock Available on a paid plan
Stichting Epilepsy Instellingen Nederland - Specialized Epilepsy Research Center
Stichting Epilepsy Instellingen Nederland is a dedicated research institution focused on advancing the understanding and treatment of epilepsy disorders. The center specializes in evaluating novel therapeutic approaches for patients with various forms of seizure disorders, with particular emphasis on developing effective adjunctive treatment strategies for individuals who continue to experience seizures despite standard medication regimens.
- Clinical evaluation of innovative antiepileptic drug candidates as add-on therapies
- Focal onset seizure management and treatment optimization
- Dose-response studies in refractory epilepsy populations
The institution's research program emphasizes evidence-based approaches to improving outcomes for patients with focal epilepsy, conducting rigorous clinical trials to assess both the efficacy and safety of emerging pharmacological interventions. Through their commitment to advancing adjunctive therapy options, the center plays a vital role in expanding treatment possibilities for individuals living with epilepsy who require additional therapeutic support beyond conventional monotherapy.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 10 by active trials.
No sponsors linked to active trials.
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 271 other sites in The Netherlands
Therapeutic Area Benchmark — The Netherlands
Select a therapeutic area to compare against other sites in The Netherlands.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: The Netherlands
Market Share
Country: The Netherlands
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Stichting Epilepsy Instellingen Nederland
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| A Randomized Phase 2 Study of Adjunctive EQU-001 for Uncontrolled Focal Onset Seizures | Equilibre Biopharmaceuticals B.V. | Phase II | Not Recruiting | — | Jul 2023 |
IMP list
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Ivermectin | 1 | Unknown | — | — |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.